| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 53162* | 2017 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8621* | 2005 |
| Mutation in blood coagulation factor V associated with resistance to activated protein C RM Bertina, BPC Koeleman, T Koster, FR Rosendaal, RJ Dirven, ... Nature 369 (6475), 64-67, 1994 | 5368 | 1994 |
| A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis SR Poort, FR Rosendaal, PH Reitsma, RM Bertina | 4145 | 1996 |
| The Scylla and Charybdis of oral anticoagulant treatment FR Rosendaal New England Journal of Medicine 335 (8), 587-589, 1996 | 3268 | 1996 |
| Malignancies, prothrombotic mutations, and the risk of venous thrombosis JW Blom, CJM Doggen, S Osanto, FR Rosendaal Jama 293 (6), 715-722, 2005 | 2451 | 2005 |
| A method to determine the optimal intensity of oral anticoagulant therapy FR Rosendaal, SC Cannegieter, FJM Van der Meer, E Briet Thrombosis and haemostasis 69 (03), 236-239, 1993 | 2323 | 1993 |
| Venous thrombosis: a multicausal disease FR Rosendaal The Lancet 353 (9159), 1167-1173, 1999 | 2214 | 1999 |
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2076 | 2011 |
| Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study T Koster, JP Vandenbroucke, FR Rosendaal, H De Ronde, E Briët, ... The Lancet 342 (8886-8887), 1503-1506, 1993 | 1706 | 1993 |
| Incidence and mortality of venous thrombosis: a population‐based study IA Næss, SC Christiansen, P Romundstad, SC Cannegieter, ... Journal of thrombosis and haemostasis 5 (4), 692-699, 2007 | 1694 | 2007 |
| Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis T Koster, JP Vandenbroucke, FR Rosendaal, E Briët, AD Blann The Lancet 345 (8943), 152-155, 1995 | 1503 | 1995 |
| Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation JP Vandenbroucke, T Koster, FR Rosendaal, E Briët, PH Reitsma, ... The Lancet 344 (8935), 1453-1457, 1994 | 1487 | 1994 |
| Hyperhomocysteinemia as a risk factor for deep-vein thrombosis M Den Heijer, T Koster, HJ Blom, GMJ Bos, E Briët, PH Reitsma, ... New England journal of medicine 334 (12), 759-762, 1996 | 1474 | 1996 |
| High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)[see comments] FR Rosendaal, T Koster, JP Vandenbroucke, PH Reitsma | 1434 | 1995 |
| The risk of myocardial infarction associated with antihypertensive drug therapies BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick, TE Raghunathan, ... Jama 274 (8), 620-625, 1995 | 1428 | 1995 |
| Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials Homocysteine Lowering Trialists' Collaboration Bmj 316 (7135), 894-898, 1998 | 1363* | 1998 |
| Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. SC Cannegieter, FR Rosendaal, E Briet Circulation 89 (2), 635-641, 1994 | 1348 | 1994 |
| Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ... The Lancet 378 (9800), 1396-1407, 2011 | 1315 | 2011 |
| Optimal oral anticoagulant therapy in patients with mechanical heart valves SC Cannegieter, FR Rosendaal, AR Wintzen, FJM Van der Meer, ... New England Journal of Medicine 333 (1), 11-17, 1995 | 1246 | 1995 |
